These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21332798)

  • 1. Airway inflammation in probiotic-treated children at 5 years.
    Kukkonen AK; Kuitunen M; Savilahti E; Pelkonen A; Malmberg P; Mäkelä M
    Pediatr Allergy Immunol; 2011 Mar; 22(2):249-51. PubMed ID: 21332798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High intestinal IgA associates with reduced risk of IgE-associated allergic diseases.
    Kukkonen K; Kuitunen M; Haahtela T; Korpela R; Poussa T; Savilahti E
    Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 1):67-73. PubMed ID: 19566584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort.
    Kuitunen M; Kukkonen K; Juntunen-Backman K; Korpela R; Poussa T; Tuure T; Haahtela T; Savilahti E
    J Allergy Clin Immunol; 2009 Feb; 123(2):335-41. PubMed ID: 19135235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial.
    Kim JY; Kwon JH; Ahn SH; Lee SI; Han YS; Choi YO; Lee SY; Ahn KM; Ji GE
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 2):e386-93. PubMed ID: 19840300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation.
    Marschan E; Kuitunen M; Kukkonen K; Poussa T; Sarnesto A; Haahtela T; Korpela R; Savilahti E; Vaarala O
    Clin Exp Allergy; 2008 Apr; 38(4):611-8. PubMed ID: 18266878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics in primary prevention of allergic disease--follow-up at 8-9 years of age.
    West CE; Hammarström ML; Hernell O
    Allergy; 2013 Aug; 68(8):1015-20. PubMed ID: 23895631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial.
    Taylor AL; Dunstan JA; Prescott SL
    J Allergy Clin Immunol; 2007 Jan; 119(1):184-91. PubMed ID: 17208600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial.
    Ou CY; Kuo HC; Wang L; Hsu TY; Chuang H; Liu CA; Chang JC; Yu HR; Yang KD
    Clin Exp Allergy; 2012 Sep; 42(9):1386-96. PubMed ID: 22925325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials.
    Elazab N; Mendy A; Gasana J; Vieira ER; Quizon A; Forno E
    Pediatrics; 2013 Sep; 132(3):e666-76. PubMed ID: 23958764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled nitric oxide, total serum IgE and allergic sensitization in childhood asthma and allergic rhinitis.
    Cardinale F; de Benedictis FM; Muggeo V; Giordano P; Loffredo MS; Iacoviello G; Armenio L
    Pediatr Allergy Immunol; 2005 May; 16(3):236-42. PubMed ID: 15853953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics during weaning reduce the incidence of eczema.
    West CE; Hammarström ML; Hernell O
    Pediatr Allergy Immunol; 2009 Aug; 20(5):430-7. PubMed ID: 19298231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial.
    Viljanen M; Savilahti E; Haahtela T; Juntunen-Backman K; Korpela R; Poussa T; Tuure T; Kuitunen M
    Allergy; 2005 Apr; 60(4):494-500. PubMed ID: 15727582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child.
    Pediatr Allergy Immunol; 1998 Aug; 9(3):116-24. PubMed ID: 9814724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis.
    Chen YS; Jan RL; Lin YL; Chen HH; Wang JY
    Pediatr Pulmonol; 2010 Nov; 45(11):1111-20. PubMed ID: 20658483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early predictors for developing allergic disease and asthma: examining separate steps in the 'allergic march'.
    Almqvist C; Li Q; Britton WJ; Kemp AS; Xuan W; Tovey ER; Marks GB;
    Clin Exp Allergy; 2007 Sep; 37(9):1296-302. PubMed ID: 17845409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atopic disease and exhaled nitric oxide in an unselected population of young adults.
    van Asch CJ; Balemans WA; Rovers MM; Schilder AG; van der Ent CK
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):59-65. PubMed ID: 18254484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up.
    Warner JO;
    J Allergy Clin Immunol; 2001 Dec; 108(6):929-37. PubMed ID: 11742270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective and risk factors for allergic diseases in high-risk children at the ages of two and five years.
    Sandini U; Kukkonen AK; Poussa T; Sandini L; Savilahti E; Kuitunen M
    Int Arch Allergy Immunol; 2011; 156(3):339-48. PubMed ID: 21720181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased activation of GATA-3, IL-2 and IL-5 of cord blood mononuclear cells in infants with IgE sensitization.
    Marschan E; Honkanen J; Kukkonen K; Kuitunen M; Savilahti E; Vaarala O
    Pediatr Allergy Immunol; 2008 Mar; 19(2):132-9. PubMed ID: 17651376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.